ATE386513T1 - Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie - Google Patents
Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämieInfo
- Publication number
- ATE386513T1 ATE386513T1 AT03766580T AT03766580T ATE386513T1 AT E386513 T1 ATE386513 T1 AT E386513T1 AT 03766580 T AT03766580 T AT 03766580T AT 03766580 T AT03766580 T AT 03766580T AT E386513 T1 ATE386513 T1 AT E386513T1
- Authority
- AT
- Austria
- Prior art keywords
- angelicin
- treatment
- thalassemia
- structural analogues
- structural
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Seasonings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Extrusion Moulding Of Plastics Or The Like (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000684A ITTO20020684A1 (it) | 2002-07-31 | 2002-07-31 | Nuovo uso dell'angelicina e di suoi analoghi strutturali. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE386513T1 true ATE386513T1 (de) | 2008-03-15 |
Family
ID=11459550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03766580T ATE386513T1 (de) | 2002-07-31 | 2003-07-30 | Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7572827B2 (de) |
| EP (1) | EP1545506B1 (de) |
| AT (1) | ATE386513T1 (de) |
| AU (1) | AU2003249472A1 (de) |
| DE (1) | DE60319241D1 (de) |
| IT (1) | ITTO20020684A1 (de) |
| WO (1) | WO2004012729A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITVE20070005A1 (it) * | 2007-01-25 | 2008-07-26 | Associazione Veneta Per La Lotta Alla Talassemia | Farmaco per la cura della talassemia, dell'anemia falciforme e di tutte le altre forme di anemia trattabili con questo, metodo di attivazione del farmaco, composizione farmaceutica avente come principio attivo il farmaco e metodo fotochemioterapico u |
| US7914821B2 (en) * | 2008-03-07 | 2011-03-29 | KO DA Pharmaceuticals Co., Ltd. | Pharmaceutical composition for prevention and/or treatment of bone loss |
| GB0911215D0 (en) | 2009-06-29 | 2009-08-12 | Univ Erasmus Medical Ct | Gamma globin therapy |
| GB201012420D0 (en) | 2010-07-23 | 2010-09-08 | Univ Erasmus Medical Ct | Foetal heamoglobin inhibitor |
| ITMI20111068A1 (it) * | 2011-06-14 | 2012-12-15 | Azienda Ospedaliera Universitaria I Ntegrata Di Ve | Trimetilangelicina come correttore di cftr in cellule dell'epitelio bronchiale |
| CN103626785A (zh) * | 2013-11-05 | 2014-03-12 | 黄河科技学院 | 一种抗凝血补骨脂有效成分及其提取分离方法、应用 |
| CN106399478A (zh) | 2016-08-31 | 2017-02-15 | 桂林优利特医疗电子有限公司 | 一种荧光探针PCR 法快速检测α/β‑地中海贫血的试剂盒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4021559A (en) * | 1974-12-30 | 1977-05-03 | Synthelabo | Method for treating sickle-cell anemia |
| US5569675A (en) * | 1994-03-07 | 1996-10-29 | Bar Ilan University | Methods of using carboxylic acid esters to increase fetal-hemoglobin levels |
| JP3850468B2 (ja) * | 1994-12-28 | 2006-11-29 | 中外製薬株式会社 | エリスロポエチンのリポソーム製剤 |
| FI100454B (fi) * | 1995-01-30 | 1997-12-15 | Leiras Oy | Hemi-tuotteiden uusi lääkinnällinen käyttö |
| WO1996040271A1 (en) | 1995-06-07 | 1996-12-19 | Yale University | Treatment of hemoglobinopathies |
-
2002
- 2002-07-31 IT IT000684A patent/ITTO20020684A1/it unknown
-
2003
- 2003-07-30 US US10/522,737 patent/US7572827B2/en not_active Expired - Fee Related
- 2003-07-30 EP EP03766580A patent/EP1545506B1/de not_active Expired - Lifetime
- 2003-07-30 AT AT03766580T patent/ATE386513T1/de not_active IP Right Cessation
- 2003-07-30 AU AU2003249472A patent/AU2003249472A1/en not_active Abandoned
- 2003-07-30 WO PCT/IB2003/003462 patent/WO2004012729A1/en active IP Right Grant
- 2003-07-30 DE DE60319241T patent/DE60319241D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60319241D1 (de) | 2008-04-03 |
| ITTO20020684A1 (it) | 2004-02-01 |
| AU2003249472A8 (en) | 2004-02-23 |
| ITTO20020684A0 (it) | 2002-07-31 |
| WO2004012729A1 (en) | 2004-02-12 |
| US20060111433A1 (en) | 2006-05-25 |
| AU2003249472A1 (en) | 2004-02-23 |
| EP1545506A1 (de) | 2005-06-29 |
| US7572827B2 (en) | 2009-08-11 |
| EP1545506B1 (de) | 2008-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60327622D1 (de) | Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien | |
| DE60320007D1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| WO2005107872A3 (en) | Treating respiratory diseases with gycopyrrolate and analogues | |
| ATE396697T1 (de) | Zuckerlacton enthaltende zusammensetzung zur haarbehandlung | |
| DE60223694D1 (de) | Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums | |
| HUP0301518A2 (hu) | Légzési rendellenességek kezelésére alkalmas száraz porkészítmény és eljárás az előállítására | |
| DE69934813D1 (de) | Verwendung von gaba analogen zur herstellung eines arzneimittels zur behandlung von manie und bipolaren erkrankungen | |
| HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
| DE60305055D1 (de) | Verwendung von ghrelin zur behandlung von unterernährung von gastrektomiepatienten | |
| ATE468849T1 (de) | Idebenon zur behandlung von muskeldystrophien | |
| ATE386513T1 (de) | Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie | |
| MXPA05013226A (es) | Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas. | |
| ATE357912T1 (de) | Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten | |
| DE602004031631D1 (de) | Verwendung von betain zur behandlung von claudicatio intermittens | |
| DE60111574D1 (de) | Bisphosphonate-enthaltenden zusammensetzungen zur vorbeugung und/oder heilung von metabolischen knochenkrankheiten, verfahren zu ihren herstellung und benutzung dieser zusammensetzungen | |
| ATE406171T1 (de) | Aplidine zur behandlung von multiplem myelom | |
| DE50313329D1 (de) | 1-phenyl-2-dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz | |
| DE60328022D1 (de) | Neue verwendung von rapamycin und strukturellen analoga hiervon | |
| DE60202684D1 (de) | Pflanzenpräparat zur behandlung und heilung von bronchialen respiratorischen schwierigkeiten | |
| DE602004029993D1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit | |
| DE60215060D1 (de) | Kräuterpräparat zur behandlung von herz-kreislauf- sowie neurologischen erkrankungen | |
| DE60315666D1 (de) | Furopyridin- und furopyrimidinderivate zur behandlung von hyperproliferativen erkrankungen | |
| ATE407925T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| DE60330233D1 (de) | Arsentherapie zur behandlung von autoimmunerkrankungen | |
| DE60129725D1 (de) | Schwefel analoge von 21-hydroxy-6,19-oxidoprogesteronen (21oh-6op) zur behandlung von glucocorticoidüberschuss |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |